Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 843.00p on 30-01-2026 at 09:40:12
Change -7.00p -0.82%
Buy 843.00p
Sell 840.00p
Last Trade: Sell 170.00 at 841.50p
Day's Volume: 39,867
Last Close: 850.00p
Open: 845.00p
ISIN: GB00BDFBVT43
Day's Range 840.00p - 850.00p
52wk Range: 232.50p - 950.00p
Market Capitalisation: £1.02b
VWAP: 842.98121p
Shares in Issue: 120.83m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 170 841.50p SI Trade
09:39:38 - 30-Jan-26
Sell* 85 840.00p SI Trade
09:38:49 - 30-Jan-26
Sell* 85 841.50p SI Trade
09:37:52 - 30-Jan-26
Sell* 255 840.00p SI Trade
09:37:15 - 30-Jan-26
Sell* 340 840.00p SI Trade
09:35:05 - 30-Jan-26
Sell* 1,105 841.50p SI Trade
09:32:33 - 30-Jan-26
Buy* 36 843.00p Automatic Execution
09:29:57 - 30-Jan-26
Sell* 750 840.24p Ordinary
09:26:37 - 30-Jan-26
Sell* 89 840.00p Automatic Execution
09:25:23 - 30-Jan-26
Sell* 305 840.00p Automatic Execution
09:25:23 - 30-Jan-26
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Jan 2026 (Fri) 845.00 850.00 840.00 850.00 39,867
29th Jan 2026 (Thu) 855.00 862.00 844.00 850.00 228,215
28th Jan 2026 (Wed) 862.00 888.00 855.00 855.00 356,464
27th Jan 2026 (Tue) 872.00 880.00 858.00 869.00 404,918
26th Jan 2026 (Mon) 870.00 879.00 860.00 864.00 114,450
23rd Jan 2026 (Fri) 884.00 884.00 852.00 871.00 192,282
22nd Jan 2026 (Thu) 900.00 900.00 850.00 853.00 362,921
21st Jan 2026 (Wed) 890.00 895.00 857.00 875.00 196,862
20th Jan 2026 (Tue) 850.00 893.00 850.00 887.00 290,275
19th Jan 2026 (Mon) 899.00 899.00 859.00 880.00 570,528
16th Jan 2026 (Fri) 917.00 950.00 899.00 899.00 384,358
15th Jan 2026 (Thu) 851.00 944.00 850.00 913.00 1,898,015
14th Jan 2026 (Wed) 743.00 805.00 729.00 804.00 449,133
13th Jan 2026 (Tue) 749.00 750.00 729.00 739.00 162,188
12th Jan 2026 (Mon) 729.00 749.00 714.00 749.00 365,142
9th Jan 2026 (Fri) 750.00 750.00 730.00 730.00 263,974
8th Jan 2026 (Thu) 721.00 765.00 717.00 751.00 710,116
7th Jan 2026 (Wed) 700.00 736.00 698.00 728.00 304,768
6th Jan 2026 (Tue) 680.00 697.00 669.00 697.00 299,916
5th Jan 2026 (Mon) 659.00 681.00 654.00 663.00 437,376
2nd Jan 2026 (Fri) 620.00 658.00 620.00 655.00 272,501
1st Jan 2026 (Thu) 617.00 617.00 617.00 617.00 0
31st Dec 2025 (Wed) 593.00 619.00 593.00 617.00 36,901
30th Dec 2025 (Tue) 622.00 632.00 616.00 620.00 143,377
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
29th Jan 2026 3:20 pm RNS Form 8.3 - Oxford Biomedica plc
29th Jan 2026 3:14 pm RNS Form 8.3 - Oxford Biomedica PLC
29th Jan 2026 9:53 am RNS Form 8.5 (EPT/RI) - Oxford Biomedica plc
29th Jan 2026 9:52 am RNS Form 8.5 (EPT/NON-RI)-Oxford Biomedica plc
29th Jan 2026 7:00 am RNS Rule 2.9 Announcement
28th Jan 2026 3:20 pm RNS Form 8.3 - Oxford Biomedica plc
28th Jan 2026 2:45 pm RNS Form 8.3 - Oxford Biomedica Plc
28th Jan 2026 2:25 pm RNS Form 8.3 - Oxford Biomedica plc
28th Jan 2026 12:08 pm RNS Form 8.3 - Oxford Biomedica PLC
28th Jan 2026 10:17 am RNS Form 8.3 - Oxford Biomedica PLC
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

IN BRIEF: Oxford Biomedica confirms fresh EQT takeover approach

14th Jan 2026 18:53

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy developer - Says it notes recent press speculation and that it has received an unsolicited approach, regarding a possible cash takeover offer, from EQT X EUR SCSp and EQT X USD SCSp, funds managed by EQT Fund Management Sarl. Says it and EQT are in preliminary discussions to explore whether EQT could make a proposal which OXB's board would want to recommend. Previous unsolicited proposals from EQT have been rejected, as OXB's board believed they undervalued it and its prospects. Company "strongly" advises shareholders to take no action at this time. Read More

LONDON BROKER RATINGS: Berenberg raises M&S; BofA cuts Barratt Redrow

9th Jan 2026 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BROKER RATINGS: RBC raises Diageo; BofA cuts JD Sports Fashion

6th Jan 2026 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: JPMorgan cuts M&G, UBS cuts Trainline

8th Dec 2025 09:39

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

Oxford BioMedica expands US footprint as buys North Carolina facility

7th Oct 2025 09:22

(Alliance News) - Oxford BioMedica PLC on Tuesday said it has closed a deal to acquire a cell and gene therapy viral vector manufacturing facility in Durham, North Carolina. Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value10,187.63
Change15.87

Login to your account

Forgot Password?

Not Registered